Advanced search
Publication Cover
Clinical Ophthalmology Volume 8, 2014 - Issue
Submit an article Journal homepage
73
Views
5
CrossRef citations to date
0
Altmetric
Original Research

European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study

Tariq Aslam1 Manchester Royal Eye Hospital, Manchester, UKCorrespondence[email protected]
,
Cécile Delcourt2 University of Bordeaux, Bordeaux, France
,
Frank Holz3 University of Bonn, Bonn, Germany
,
Alfredo García-Layana4 Clínica Universidad de Navarra, Pamplona, Spain
,
Anita Leys5 University Hospitals, Leuven, Belgium
,
Rufino M Silva6 University of Coimbra, Coimbra, Portugal
&
Eric Souied7 Université Paris Est Créteil, Créteil, France
 show all
Pages 2045-2053 | Published online: 10 Oct 2014

References

  • BresslerNMAge-related macular degeneration is the leading cause of blindnessJAMA2004291151900190115108691
  • FriedmanDSO’ColmainBJMuñozBEye Diseases Prevalence Research GroupPrevalence of age-related macular degeneration in the United StatesArch Ophthalmol2004122456457215078675
  • ChakravarthyUWongTYFletcherAClinical risk factors for age-related macular degeneration: a systematic review and meta-analysisBMC Ophthalmol2010103121144031
  • MillerJWAge-related macular degeneration revisited – piecing the puzzle: the LXIX Edward Jackson memorial lectureAm J Ophthalmol2013155113523245386
  • ZarbinMACurrent concepts in the pathogenesis of age-related macular degenerationArch Ophthalmol2004122459861415078679
  • BeattySKohHPhilMHensonDBoultonMThe role of oxidative stress in the pathogenesis of age-related macular degenerationSurv Ophthalmol200045211513411033038
  • QuerquesGBenlianPChanuBNutritional AMD treatment phase I (NAT-1): feasibility of oral DHA supplementation in age-related macular degenerationEur J Ophthalmol200919110010619123156
  • Age-Related Eye Disease Study 2 Research GroupLutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trialJAMA2013309192005201523644932
  • RicherSARMD – pilot (case series) environmental intervention dataJ Am Optom Assoc1999701243610457679
  • ZeimerMDietzelMHenseHWHeimesBAustermannUPauleikhoffDProfiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA studyInvest Ophthalmol Vis Sci20125384852485922743321
  • YingGSHuangJMaguireMGComparison of Age-related Macular Degeneration Treatments Trials Research GroupBaseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationOphthalmology2013120112212923047002
  • AugoodCChakravarthyUYoungIOily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degenerationAm J Clin Nutr200888239840618689376
  • DelcourtCCarrièreIDelageMBarberger-GateauPSchalchWPOLA Study GroupPlasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA StudyInvest Ophthalmol Vis Sci20064762329233516723441
  • Age-Related Eye Disease Study Research GroupA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Arch Ophthalmol2001119101417143611594942
  • AREDS2 Research GroupChewEYClemonsTSanGiovanniJPThe Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)Ophthalmology2012119112282228922840421

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.